Ralf Kuriyel - 14 May 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Senior VP, R&D
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
14 May 2021
Net transactions value
-$122,326
Form type
4
Filing time
18 May 2021, 07:50:05 UTC
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Sale $122,326 -710 -2.8% $172.29 24,555 14 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units.
F2 $172.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.26 to $172.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

Exhibit 24.1: Power of Attorney